These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28822593)

  • 1. Decreased expression of microRNA-122 is associated with an unfavorable prognosis in childhood acute myeloid leukemia and function analysis indicates a therapeutic potential.
    Yang J; Yuan Y; Yang X; Hong Z; Yang L
    Pathol Res Pract; 2017 Sep; 213(9):1166-1172. PubMed ID: 28822593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia.
    Wang X; Zuo D; Yuan Y; Yang X; Hong Z; Zhang R
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):169-180. PubMed ID: 27738758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia.
    Hong Z; Zhang R; Qi H
    Cancer Biomark; 2018 Feb; 21(2):269-275. PubMed ID: 29226854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
    Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
    Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia.
    Lin X; Wang Z; Zhang R; Feng W
    Clin Transl Oncol; 2015 May; 17(5):358-64. PubMed ID: 25301405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Cordeiro A; Tormo M; Escoda L; Ribera JM; Arnan M; Heras I; Gallardo D; Bargay J; Queipo de Llano MP; Salamero O; Martí JM; Sampol A; Pedro C; Hoyos M; Pratcorona M; Castellano JJ; Nomdedeu M; Risueño RM; Sierra J; Monzó M; Navarro A; Esteve J
    Blood Cancer J; 2015 Oct; 5(10):e352. PubMed ID: 26430723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
    Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
    Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of miR-29a expression in pediatric acute myeloid leukemia.
    Zhu C; Wang Y; Kuai W; Sun X; Chen H; Hong Z
    Clin Biochem; 2013 Jan; 46(1-2):49-53. PubMed ID: 22981932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia.
    Wang Z; Hong Z; Gao F; Feng W
    Mol Cell Biochem; 2013 Nov; 383(1-2):59-65. PubMed ID: 23864342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia.
    Zhang P; Sun D; Sun X; Li H
    Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
    Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of miR-96 in patients with acute myeloid leukemia.
    Zhao J; Lu Q; Zhu J; Fu J; Chen YX
    Diagn Pathol; 2014 Mar; 9():76. PubMed ID: 24678958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-592 functions as a tumor suppressor in acute myeloid leukemia by targeting ROCK1 and predicts patients' prognosis.
    Xu Y; Li K; Wang SB; Yang SG
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1610-1619. PubMed ID: 30840284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
    Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
    Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
    Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.
    Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Del Carmen Alarcón-Romero L; Saavedra-Herrera MV; Rivera-Ramírez AB; Garzón-Barrientos VH; Leyva-Vázquez MA
    Oncol Rep; 2015 Apr; 33(4):1639-49. PubMed ID: 25672522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
    Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X
    Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
    Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y
    Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.